The present invention relates to diaryl pyrimidine-2,4-diamines,
pharmaceutical compositions thereof, and the use of the compounds and
compositions for the inhibition of kinases. The compounds, analogs, and
pharmaceutically acceptable salts thereof, and pharmaceutical
compositions can be used in the treatment and prevention of cancer.